US EditionBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Summary by Com-unik.info
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five brokerages that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage